Pancreatic Cancer Action Network Invites Applications for 2020 Translational Research Grants

The Pancreatic Cancer Action Network (PanCAN) is inviting applications for its Translational Research Grants program.

Through the program, grants of $500,000 over two years (with potential for a third year) will be awarded in support of research aimed at identifying novel targets and approaches to the treatment of pancreatic cancer or the understanding and circumvention of treatment resistance. The program seeks to fund high-priority pancreatic cancer research that is poised for important translational next steps. Of particular interest are research projects that fall into at least one of the following areas of research: immune context and tumor microenvironment interactions; regulators of pathogenesis, progression and metabolism, with particular interest in epigenetic mechanisms; and transcriptional networks essential for viability and maintenance of malignant phenotype.

PanCAN expects to award four grants through the program.

To be eligible, applicants must have a doctoral degree (including PhD, MD, DO, DC, ND, DDS, DVM, ScD, DNS, PharmD, or the equivalent) in the biomedical sciences or in a field applicable to health science research and not currently be a candidate for a further doctoral degree. The contact principal investigator must be affiliated with an accredited academic, medical, or research institution. International institutions are included.

Click here for more information